Andy Cohen is admitting to dabbling in the world of weight loss drugs.
The “Real Housewives” executive producer opened up about “micro-dosing” on an unnamed GLP-1 weight loss drug on his SiriusXM radio show “Andy Cohen Live,” which he said led him to lose “a good chunk of weight.”
“I was really unhappy with my weight,” he told listeners on air Tuesday, Sept. 9. “My doctor and I talked about this last year. (He) had recommended a GLP-1 a few times to not only address what I was feeling about my weight, but treat plaque in my arteries and high blood pressure.”
Cohen, 57, suggested he felt hesitant about trying weight loss drugs, but “finally said yes.” He says the “revolutionary” drug – in combination with a “pretty rigorous” workout routine – curbed his snacking and led him to lose 25 pounds. He has since stopped using the drug, he said.
Howard Stern pranks fans with Andy Cohen amid SiriusXM contract talks
Howard Stern pranked fans by letting Andy Cohen open his show, sparking rumors he was leaving SiriusXM before returning to clear the air.
Straight Arrow News
“My appetite returned from the micro-dose, but I feel like it caused me to reframe my relationship with food,” he added.
Several stars – including Serena Williams, Rosie O’Donnell, Oprah Winfrey and Kelly Clarkson – have touted weight loss drugs like Ozempic, Mounjaro, Wegovy, Zepbound and other injectable prescription medicines.
The “Watch What Happens Live” host said he knew he would disclose his use of the weight loss drug because of the nature of his work.
“I feel so strongly that I can’t be the one asking all the personal questions of, specifically, the Housewives. ‘What did you do to your face? How did you do the weight loss?’ And then be the guy who’s suddenly lost 25 pounds but isn’t mentioning it,” he said.
Cohen acknowledged he is “privileged to have access to a GLP-1” and that “everybody should through insurance.”
Mounjaro currently sells for $1,079.77 per prescription, according to the Lilly website, though the final retail price may vary depending on insurance coverage. Wegovy and Ozempic, the weight loss medications made by Novo Nordisk, are currently listed at $499 per monthly dose for the uninsured. The drugs are often covered by insurance for people who have diabetes.
Contributing: Edward Segarra, Eduardo Cuevas, Ken Alltucker